Skip to main content
. 2020 Nov 28;19:1533033820973280. doi: 10.1177/1533033820973280

Table 1.

Promiscuous Ligand Recognition by FPRs.

Source Diseases Agonists FPR1 FPR2 FPR3
(Fpr1) (Fpr2) (Fpr3)
Bacteria Infection fMLF (E. Coli) ++++ ++
Listeria peptides ++++ +++
 Stomach cancer Hp(2-20) - +++ ++
Host Inflammation Serum amyloid A - ++++
 Alzheimer’s Aβ42, Humanin + ++++
 Prion disease Prp106-126 - +++
 Angiogenesis Annexin 1(ANXA1) ++ +++ ++
 Tissue damage Mitochondria pep +++ +++
F2 L (Heme) - ++ ++++
 Coagulation uPAR frag - +++
 Host defense LL37 (CRAMP) - +++
Cathepsin G +++
 Cancer ANXA1 ++ +++

+ Denotes the relative potency of the ligands to activate a given FPR References: 1, 2, 16).